Catalyst Wire Dossier Catalyst Wire Dossier

Claudiximab

· Ganymed Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Claudiximab, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer [Phase 1]

See pricing